BioLineRx (BLRX) – Trading Halts
-
BioLineRx (BLRX) Announces FDA Approval of APHEXDA in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Patients with
-
BioLineRx (BLRX) Halted, News Pending
-
-
Back to BLRX Stock Lookup